JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 4, 2005; DOI: 10.1124/jpet.105.092403


0022-3565/06/3163-1351-1359$20.00
JPET 316:1351-1359, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.092403v1
316/3/1351    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stórustovu, S. i
Right arrow Articles by Ebert, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stórustovu, S. i
Right arrow Articles by Ebert, B.

NEUROPHARMACOLOGY

Pharmacological Characterization of Agonists at {delta}-Containing GABAA Receptors: Functional Selectivity for Extrasynaptic Receptors Is Dependent on the Absence of {gamma}2

Signe í Stórustovu, and Bjarke Ebert

Department of Electrophysiology, H. Lundbeck A/S, Valby, Denmark

Several groups have characterized the pharmacology of {alpha}4- or {alpha}6beta3{delta}-containing GABAA receptors expressed in different cell systems. We have previously demonstrated that the pharmacological profiles of a series of GABAA receptor agonists are highly dependent on the {alpha} subunit and little on the beta and {gamma} subunits, so to further understand the contribution of the different subunits in the GABAA receptor complex, we characterized a series of full agonists, partial agonists, and antagonists at {alpha}4beta3, {alpha}4beta3{delta}, and {alpha}6beta3{delta} receptors expressed in Xenopus oocytes. Little or no difference was seen when the compounds were compared at {alpha}beta- and {alpha}beta{delta}-containing receptors, whereas a significant reduction in both potency and relative efficacy was observed compared with {alpha}beta{gamma}-containing receptors described in the literature. These data clearly confirm that the presence of the {delta} subunit in heterotrimeric receptors is a strong determinant of the increased pharmacological activity of compounds with agonist activity. The very similar agonist pharmacology of {alpha}beta- and {alpha}beta{delta}-containing receptors, which is significantly different from that of {alpha}beta{gamma}-containing receptors, shows that whereas the presence of a {gamma} subunit impairs the response to an agonist stimulation of the {alpha}beta receptor complex, the {delta} subunit does not affect this in any way. Taken together, these data are well in line with the idea that {alpha}4beta3{delta} may contribute to the pharmacological action of exogenously applied agonists and may explain why systemically active compounds such as gaboxadol and muscimol in vivo appear to act as selective extrasynaptic GABAA agonists.


Received July 11, 2005; accepted September 16, 2005.

Address correspondence to: Dr. Bjarke Ebert, Department of Electrophysiology, H. Lundbeck A/S, 9 Ottiliavej, DK-2500 Valby, Denmark. E-mail: bjeb{at}lundbeck.com




This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
E. I. Krook-Magnuson, P. Li, S. M. Paluszkiewicz, and M. M. Huntsman
Tonically Active Inhibition Selectively Controls Feedforward Circuits in Mouse Barrel Cortex
J Neurophysiol, August 1, 2008; 100(2): 932 - 944.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
W. Hevers, S. H. Hadley, H. Luddens, and J. Amin
Ketamine, But Not Phencyclidine, Selectively Modulates Cerebellar GABAA Receptors Containing {alpha}6 and {delta} Subunits
J. Neurosci., May 14, 2008; 28(20): 5383 - 5393.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Jia, M. Yue, D. Chandra, G. E. Homanics, P. A. Goldstein, and N. L. Harrison
Isoflurane Is a Potent Modulator of Extrasynaptic GABAA Receptors in the Thalamus
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1127 - 1135.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. P. Barrera, J. Betts, H. You, R. M. Henderson, I. L. Martin, S. M. J. Dunn, and J. M. Edwardson
Atomic Force Microscopy Reveals the Stoichiometry and Subunit Arrangement of the {alpha}4{beta}3{delta} GABAA Receptor
Mol. Pharmacol., March 1, 2008; 73(3): 960 - 967.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. B. Herd, A. R. Haythornthwaite, T. W. Rosahl, K. A. Wafford, G. E. Homanics, J. J. Lambert, and D. Belelli
The expression of GABAA {beta} subunit isoforms in synaptic and extrasynaptic receptor populations of mouse dentate gyrus granule cells
J. Physiol., February 15, 2008; 586(4): 989 - 1004.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. K. Ade, M. J. Janssen, P. I. Ortinski, and S. Vicini
Differential Tonic GABA Conductances in Striatal Medium Spiny Neurons
J. Neurosci., January 30, 2008; 28(5): 1185 - 1197.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. Jia, M. Yue, D. Chandra, A. Keramidas, P. A. Goldstein, G. E. Homanics, and N. L. Harrison
Taurine Is a Potent Activator of Extrasynaptic GABAA Receptors in the Thalamus
J. Neurosci., January 2, 2008; 28(1): 106 - 115.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.